The Language Of Medicine

Biotechnology and medical-device company stock prices are down, credit is tight and businesses are struggling to keep going.

Two doctors have been ordered to separate themselves from the company they currently work for as part of a contract dispute with a previous employer, causing an absence at their new jobs at a time of rapid growth.

Creditors of a nonprofit senior living community have asked a judge to appoint a receiver to sell the complex to satisfy debts totaling more than $48.4 million.

A University of Central Florida professor is one step closer to finding a new treatment for breast cancer, after developing two new promising compounds that he has already patented.

Cash is king, and life sciences companies expecting to survive 2009 better have lots of it.